Back to Browse Journals » Infection and Drug Resistance » Volume 1

Current and novel antibiotics against resistant Gram-positive bacteria

Authors Federico Perez, Robert A Salata, Robert A Bonomo

Published Date September 2008 Volume 2008:1 Pages 27—44


Published 9 September 2008

Federico Perez1, Robert A Salata1, Robert A Bonomo2

1Division of Infectious Diseases and HIV Medicine, University Hospitals Case Medical Center, Cleveland OH, USA; 2Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH, USA

Abstract: The challenge posed by resistance among Gram-positive bacteria, epitomized by methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE) and vancomycin-intermediate and -resistant S. aureus (VISA and VRSA) is being met by a new generation of antimicrobials. This review focuses on the new β-lactams with activity against MRSA (ceftobiprole and ceftaroline) and on the new glycopeptides (oritavancin, dalbavancin, and telavancin). It will also consider the role of vancomycin in an era of existing alternatives such as linezolid, daptomycin and tigecycline. Finally, compounds in early development are described, such as iclaprim, friulimicin, and retapamulin, among others.

Keywords: Gram-positive bacteria, vancomycin, anti-MRSA cephalosporins, lipoglycopeptides, daptomycin, linezolid, tigecycline

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Consideration of generated beam angles increases the accuracy of ultrasonic displacement measurements

Sumi C, Takanashi Y, Ichimaru K

Reports in Medical Imaging 2012, 5:23-50

Published Date: 9 March 2012

Insight into 144 patients with ocular vascular events during VEGF antagonist injections

Mansour AM, Shahin M, Kofoed PK, Parodi MB, Shami M, Schwartz SG

Clinical Ophthalmology 2012, 6:343-363

Published Date: 6 March 2012

Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysis

William C Dooley, James C Wurzer, Mohamed Megahy, et al

OncoTargets and Therapy 2011, 4:13-20

Published Date: 12 January 2011

A systematic writing program as a tool in the grief process: part 1

Bodil Furnes, Elin Dysvik

Patient Preference and Adherence 2010, 4:425-431

Published Date: 6 December 2010

Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination

Giuseppe Derosa, Sibilla AT Salvadeo

Integrated Blood Pressure Control 2010, 3:21-30

Published Date: 19 May 2010

Induction of cytotoxicity, apoptosis and cell cycle arrest by 1-t-butyl carbamoyl, 7-methyl-indole-3-ethyl isothiocyanate (NB7M) in nervous system cancer cells

Laurent Brard, Rakesh K Singh, Kyu Kwang Kim, Thilo S Lange, Giselle L Saulier Sholler

Drug Design, Development and Therapy 2008, 2:61-69

Published Date: 9 April 2008